Biological variation estimates for prostate specific antigen from the European Biological Variation Study; consequences for diagnosis and monitoring of prostate cancer

Carobene, Anna; Guerra, Elena; Locatelli, Massimo; Cucchiara, Vito; Briganti, Alberto; Aarsand, Aasne; Coskun, ABDURRAHMAN; Diaz-Garzon, Jorge; Fernandez-Calle, Pilar; Roraas, Thomas; Sandberg, Sverre; Jonker, Niels; Ceriotti, Ferruccio

doi:10.1016/j.cca.2018.07.043

Biological variation estimates for prostate specific antigen from the European Biological Variation Study; consequences for diagnosis and monitoring of prostate cancer

Copy For Citation

Carobene A., Guerra E., Locatelli M., Cucchiara V., Briganti A., Aarsand A. K. , ...More

CLINICA CHIMICA ACTA, vol.486, pp.185-191, 2018 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 486
Publication Date: 2018
Doi Number: 10.1016/j.cca.2018.07.043
Title of Journal : CLINICA CHIMICA ACTA
Page Numbers: pp.185-191

Abstract

Background: Prostate-specific antigen (PSA) is central in the diagnosis of prostate cancer. However, high-quality biological variation (BV) estimates for PSA are scarce. Here BV estimates from the European Biological Variation Study (EuBIVAS) for total (tPSA), free (fPSA), conjugated PSA (cPSA), and percent free PSA (%fPSA) are provided.